Evaro is an NHS-licensed digital healthcare platform founded by medical professionals to embed regulated online care within consumer brands’ existing digital experiences. Its healthcare-as-a-service stack covers asynchronous consultations, remote diagnostics, prescribing, dispensing and aftercare, and can be integrated in a short timeframe with minimal engineering lift for partners. The system supports treatment across more than 80 common conditions and has already served over two million patients through various consumer-facing brands. By enabling trusted non-clinical companies to add healthcare offerings, Evaro creates new revenue streams and deeper customer engagement while helping relieve pressure on overstretched UK primary care. The company generates income from these brand partnerships, though detailed revenue figures were not disclosed. With fresh capital in hand, Evaro intends to expand its reach and further develop its infrastructure for the UK market. The new funding round signals investor confidence in the firm’s traction and its ability to scale regulated digital healthcare delivery.

Total raised

$27M

Funding rounds

2

Latest round

Series A

Latest activity

Jan 2026